{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:46Z","timestamp":1772119306883,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Construction project of Fujian Medical Center of Hematology","award":["Min201704"],"award-info":[{"award-number":["Min201704"]}]},{"name":"the National and Fujian Provincial Key Clinical Specialty Discipline Construction Program, P.R.C"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-024-05992-6","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T22:01:55Z","timestamp":1726264915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia"],"prefix":"10.1007","author":[{"given":"Shuxia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangxiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng\u2019e","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"5992_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov PV, Ghafari M, Beer M, Lythgoe K, Simmonds P, Stilianakis NI et al (2023) The evolution of SARS-CoV-2. Nat Rev Microbiol 21:361\u2013379. https:\/\/doi.org\/10.1038\/s41579-023-00878-2","journal-title":"Nat Rev Microbiol"},{"key":"5992_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-020-2404-8","volume":"584","author":"S Hsiang","year":"2020","unstructured":"Hsiang S, Allen D, Annan-Phan S, Bell K, Bolliger I, Chong T et al (2020) The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature 584:262\u2013267. https:\/\/doi.org\/10.1038\/s41586-020-2404-8","journal-title":"Nature"},{"key":"5992_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1177\/08850666231166344","volume":"38","author":"A Mehri","year":"2023","unstructured":"Mehri A, Sotoodeh Ghorbani S, Farhadi-Babadi K, Rahimi E, Barati Z, Taherpour N et al (2023) Risk factors Associated with Severity and Death from COVID-19 in Iran: a systematic review and Meta-analysis study. J Intensive Care Med 38:825\u2013837. https:\/\/doi.org\/10.1177\/08850666231166344","journal-title":"J Intensive Care Med"},{"key":"5992_CR4","doi-asserted-by":"publisher","first-page":"e2210949","DOI":"10.1002\/adma.202210949","volume":"35","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang M, Wang X, Yang F, Cao Z, Wang L et al (2023) Dressing Bacteria with a hybrid Immunoactive Nanosurface to Elicit Dual Anticancer and antiviral immunity. Adv Mater 35:e2210949. https:\/\/doi.org\/10.1002\/adma.202210949","journal-title":"Adv Mater"},{"key":"5992_CR5","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1182\/blood.2020008824","volume":"136","author":"A Vijenthira","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B et al (2020) Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood 136:2881\u20132892. https:\/\/doi.org\/10.1182\/blood.2020008824","journal-title":"Blood"},{"key":"5992_CR6","doi-asserted-by":"publisher","first-page":"e30662","DOI":"10.7759\/cureus.30662","volume":"14","author":"M Mericliler","year":"2022","unstructured":"Mericliler M, Narayan G (2022) Outcomes of COVID-19 in adult males with Hemophilia A: a propensity score-matched analysis. Cureus 14:e30662. https:\/\/doi.org\/10.7759\/cureus.30662","journal-title":"Cureus"},{"key":"5992_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844\u2013847. https:\/\/doi.org\/10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"key":"5992_CR8","doi-asserted-by":"publisher","unstructured":"Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW et al (2020) WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia. 26 Suppl 6:1-158. https:\/\/doi.org\/10.1111\/hae.14046","DOI":"10.1111\/hae.14046"},{"issue":"1","key":"5992_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41572-021-00285-y","volume":"7","author":"Haemophilia","year":"2021","unstructured":"Haemophilia (2021) Nat Rev Dis Primers 7(1):44. https:\/\/doi.org\/10.1038\/s41572-021-00285-y","journal-title":"Nat Rev Dis Primers"},{"key":"5992_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/hae.14001","volume":"26","author":"C Hermans","year":"2020","unstructured":"Hermans C, Weill A, Pierce GF (2020) The COVID-19 pandemic: New global challenges for the haemophilia community. Haemophilia 26:371\u2013372. https:\/\/doi.org\/10.1111\/hae.14001","journal-title":"Haemophilia"},{"key":"5992_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd.2018.70","volume":"17","author":"R Peters","year":"2018","unstructured":"Peters R, Harris T (2018) Advances and innovations in haemophilia treatment. Nat Rev Drug Discov 17:493\u2013508. https:\/\/doi.org\/10.1038\/nrd.2018.70","journal-title":"Nat Rev Drug Discov"},{"key":"5992_CR12","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","volume":"344","author":"PM Mannucci","year":"2001","unstructured":"Mannucci PM, Tuddenham EG (2001) The hemophilias\u2013from royal genes to gene therapy. N Engl J Med 344:1773\u20131779. https:\/\/doi.org\/10.1056\/NEJM200106073442307","journal-title":"N Engl J Med"},{"key":"5992_CR13","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1182\/blood.2022017780","volume":"141","author":"L Malec","year":"2023","unstructured":"Malec L, Van Damme A, Chan AKC, Spasova M, Jain N, Sensinger C et al (2023) Recombinant factor VIII fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study. Blood 141:1982\u20131989. https:\/\/doi.org\/10.1182\/blood.2022017780","journal-title":"Blood"},{"key":"5992_CR14","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/hae.14381","volume":"27","author":"DP Hart","year":"2021","unstructured":"Hart DP, Alamelu J, Bhatnagar N, Biss T, Collins PW, Hall G et al (2021) Immune tolerance induction in severe haemophilia A: a UKHCDO inhibitor and paediatric working party consensus update. Haemophilia 27:932\u2013937. https:\/\/doi.org\/10.1111\/hae.14381","journal-title":"Haemophilia"},{"key":"5992_CR15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1182\/blood-2011-11-393371","volume":"120","author":"AM Shibeko","year":"2012","unstructured":"Shibeko AM, Woodle SA, Lee TK, Ovanesov MV (2012) Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids. Blood 120:891\u2013899. https:\/\/doi.org\/10.1182\/blood-2011-11-393371","journal-title":"Blood"},{"key":"5992_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/hae.13641","volume":"25","author":"EC Rodriguez-Merchan","year":"2019","unstructured":"Rodriguez-Merchan EC, Valentino LA, Emicizumab (2019) Review of the literature and critical appraisal. Haemophilia 25:11\u201320. https:\/\/doi.org\/10.1111\/hae.13641","journal-title":"Haemophilia"},{"key":"5992_CR17","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMc1712683","volume":"377","author":"H Wada","year":"2017","unstructured":"Wada H, Matsumoto T, Katayama N (2017) Emicizumab Prophylaxis in Hemophilia A with inhibitors. N Engl J Med 377:2193\u20132194. https:\/\/doi.org\/10.1056\/NEJMc1712683","journal-title":"N Engl J Med"},{"key":"5992_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa1803550","volume":"379","author":"J Mahlangu","year":"2018","unstructured":"Mahlangu J, Oldenburg J, Paz-Priel I, Negrier C, Niggli M, Mancuso ME et al (2018) Emicizumab Prophylaxis in patients who have hemophilia A without inhibitors. N Engl J Med 379:811\u2013822. https:\/\/doi.org\/10.1056\/NEJMoa1803550","journal-title":"N Engl J Med"},{"key":"5992_CR19","doi-asserted-by":"publisher","first-page":"20507","DOI":"10.1021\/jacs.2c09484","volume":"144","author":"Z Yuan","year":"2022","unstructured":"Yuan Z, Li B, Gu W, Luozhong S, Li R, Jiang S (2022) Mitigating the immunogenicity of AAV-Mediated gene therapy with an immunosuppressive phosphoserine-containing zwitterionic peptide. J Am Chem Soc 144:20507\u201320513. https:\/\/doi.org\/10.1021\/jacs.2c09484","journal-title":"J Am Chem Soc"},{"key":"5992_CR20","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","volume":"119","author":"CR Hay","year":"2012","unstructured":"Hay CR, DiMichele DM (2012) The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood 119:1335\u20131344. https:\/\/doi.org\/10.1182\/blood-2011-08-369132","journal-title":"Blood"},{"issue":"Suppl 1","key":"5992_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.12860","volume":"22","author":"Y Dargaud","year":"2016","unstructured":"Dargaud Y, Pavlova A, Lacroix-Desmazes S, Fischer K, Soucie M, Claeyssens S et al (2016) Achievements, challenges and unmet needs for haemophilia patients with inhibitors: report from a symposium in Paris, France on 20 November 2014. Haemophilia 22(Suppl 1):1\u201324. https:\/\/doi.org\/10.1111\/hae.12860","journal-title":"Haemophilia"},{"key":"5992_CR22","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1111\/hae.14130","volume":"26","author":"S von Mackensen","year":"2020","unstructured":"von Mackensen S, Halimeh S, Siebert M, Wermes C, Hassenpflug W, Holstein K et al (2020) Impact of COVID-19 pandemic on mental health of patients with inherited bleeding disorders in Germany. Haemophilia 26:e272\u2013e81. https:\/\/doi.org\/10.1111\/hae.14130","journal-title":"Haemophilia"},{"key":"5992_CR23","doi-asserted-by":"publisher","first-page":"m4529","DOI":"10.1136\/bmj.m4529","volume":"371","author":"E Eythorsson","year":"2020","unstructured":"Eythorsson E, Helgason D, Ingvarsson RF, Bjornsson HK, Olafsdottir LB, Bjarnadottir V et al (2020) Clinical spectrum of coronavirus disease 2019 in Iceland: population based cohort study. BMJ 371:m4529. https:\/\/doi.org\/10.1136\/bmj.m4529","journal-title":"BMJ"},{"key":"5992_CR24","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/postgradmedj-2020-138234","volume":"96","author":"S Umakanthan","year":"2020","unstructured":"Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF et al (2020) Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 96:753\u2013758. https:\/\/doi.org\/10.1136\/postgradmedj-2020-138234","journal-title":"Postgrad Med J"},{"key":"5992_CR25","doi-asserted-by":"publisher","unstructured":"Wadowski PP, Panzer B, J\u00f3zkowicz A, Kopp CW, Gremmel T, Panzer S et al (2023) Microvascular thrombosis as a critical factor in severe COVID-19. Int J Mol Sci 24(3). https:\/\/doi.org\/10.3390\/ijms24032492","DOI":"10.3390\/ijms24032492"},{"key":"5992_CR26","doi-asserted-by":"publisher","first-page":"e0269738","DOI":"10.1371\/journal.pone.0269738","volume":"18","author":"S Stanford","year":"2023","unstructured":"Stanford S, Roy A, Rea C, Harris B, Ashton A, Mangles S et al (2023) Pilot study to evaluate hypercoagulation and inflammation using rotational thromboelastometry and calprotectin in COVID-19 patients. PLoS ONE 18:e0269738. https:\/\/doi.org\/10.1371\/journal.pone.0269738","journal-title":"PLoS ONE"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05992-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05992-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T22:02:21Z","timestamp":1726264941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05992-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":26,"alternative-id":["5992"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05992-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4476895\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,14]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee of Fujian Medical University Union Hospital (approval No. 2023KY107). The participants were informed that their participation was entirely voluntary and that they could withdraw without providing any justification or answering any survey questions at any time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}